Stock-Based Compensation - SAR Activity (Detail) - Stock Appreciation Rights [Member] - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Schedule Of Stock Appreciation Rights Activity [Line Items]
SARs Outstanding, Beginning Balance	233,969	200,998	293,276
Granted, SARs	51,916	32,971	15,029
Exercised, SARs	(53,036)	0	(102,562)
Canceled, SARs	(12,969)	0	(4,745)
Shares Outstanding, SARs, Ending Balance	219,880	233,969	200,998
Vested, SARs	150,657
Exercisable, SARs	150,657
Outstanding, Weighted Average Grant Price Per Share, Beginning Balance	$ 40.64	$ 33.86	$ 22.15
Granted, Weighted Average Grant Price Per Share	56.8	82.01	104.56
Exercised, Weighted Average Grant Price Per Share	11.95	0	9.45
Canceled, Weighted Average Grant Price Per Share	75.25	0	61.66
Outstanding, Weighted Average Grant Price Per Share, Ending Balance	49.34	$ 40.64	$ 33.86
Vested, Weighted Average Grant Price Per Share	41.54
Exercisable, Weighted Average Grant Price Per Share	$ 41.54
Weighted Average Remaining Contractual Life, Outstanding	6 years 3 months 18 days
Weighted Average Remaining Contractual Life, Vested	5 years
Weighted Average Remaining Contractual Life, Exercisable	5 years
Aggregate Intrinsic Value, Outstanding	$ 6,393,512
Aggregate Intrinsic Value, Vested	6,378,706
Aggregate Intrinsic Value, Exercisable	$ 6,378,706